How should I start and titrate an SSRI (e.g., escitalopram), including dosing, monitoring for side effects and contraindications, and alternative antidepressants if the SSRI is not tolerated?

Starting and Managing SSRI Therapy (Escitalopram)

Start escitalopram at 10 mg once daily (morning or evening, with or without food) and increase to 20 mg only after a minimum of 1 week in adults or 3 weeks in adolescents if needed, though 10 mg is often sufficient for efficacy. 1

Initial Dosing Strategy

Begin with a subtherapeutic "test" dose if the patient is particularly anxious or sensitive to medications, as SSRIs can paradoxically cause initial anxiety or agitation 2. For escitalopram specifically:

• Adults: 10 mg once daily is the recommended starting and often therapeutic dose 1
• Adolescents (12-17 years): 10 mg once daily; wait minimum 3 weeks before considering increase to 20 mg 1
• Elderly patients or hepatic impairment: Maximum 10 mg/day 1
• Severe renal impairment: Use with caution 1

Why Escitalopram is Preferred

Escitalopram/citalopram have the least effect on CYP450 enzymes compared to other SSRIs, resulting in lower propensity for drug-drug interactions 2. This makes them safer choices when patients are on multiple medications.

Titration Approach

Use slow, conservative titration at 1-2 week intervals for shorter half-life SSRIs like escitalopram, sertraline, and citalopram 2. The rationale:

• SSRIs show logarithmic response: statistically significant improvement by week 2, clinically significant by week 6, maximal by week 12 or later 2
• Higher doses are associated with more adverse effects without necessarily greater efficacy 2
• The benefit-to-harm ratio should guide dose optimization, not arbitrary maximum doses 2

For escitalopram specifically: Fixed-dose trials showed 10 mg and 20 mg both effective, but 20 mg failed to demonstrate greater benefit over 10 mg 1. Therefore, many patients achieve remission at 10 mg without needing dose escalation.

Critical Contraindications

Absolute contraindications 1:

• MAOIs: Must have 14-day washout period before starting or after stopping escitalopram
• Pimozide (Orap): Causes serious cardiac arrhythmias when combined
• Known hypersensitivity to escitalopram or citalopram

Relative contraindications requiring caution 2:

• Long QT syndrome or QT-prolonging drugs: Citalopram/escitalopram can prolong QT interval, particularly at doses >40 mg/day (avoid in long QT) 2, 3
• Seizure disorders: Use cautiously 2
• Bleeding disorders or anticoagulant use: SSRIs increase bleeding risk, especially with NSAIDs, aspirin, or warfarin 2

Monitoring for Side Effects

First 24-48 Hours After Initiation or Dose Changes

Monitor closely for serotonin syndrome, especially if combining with other serotonergic drugs 2:

• Mental status changes (confusion, agitation, anxiety)
• Neuromuscular hyperactivity (tremors, clonus, hyperreflexia, muscle rigidity)
• Autonomic hyperactivity (hypertension, tachycardia, diaphoresis, vomiting, diarrhea)
• Advanced symptoms: fever, seizures, arrhythmias, unconsciousness

Never combine with 2:

• MAOIs (phenelzine, isocarboxazid, linezolid, methylene blue)
• Use extreme caution with: tramadol, meperidine, methadone, fentanyl, dextromethorphan, St. John's wort, tryptophan

First Few Weeks

Monitor for suicidal ideation/behavior - FDA boxed warning through age 24 2, 1:

• Pooled absolute risk: 1% on antidepressants vs 0.2% on placebo
• Risk difference 0.7% (NNH = 143 vs NNT = 3 for response)
• Close monitoring especially in first months and after dose adjustments

Watch for behavioral activation/agitation 2:

• More common in younger children than adolescents
• Presents as motor restlessness, insomnia, impulsiveness, disinhibited behavior, aggression
• May require dose reduction or discontinuation

Common Side Effects (First Weeks)

Most adverse effects emerge within first few weeks 2, 1:

• Gastrointestinal: nausea, diarrhea, dry mouth, constipation
• CNS: headache, dizziness, insomnia or somnolence, tremor
• Other: sweating, sexual dysfunction, fatigue

In children/adolescents, also monitor 1:

• Height and weight (potential growth effects)
• Increased thirst, abnormal muscle movements, nosebleeds

Ongoing Monitoring

• Sexual dysfunction: Delayed ejaculation, decreased libido, anorgasmia - discuss openly as treatments exist 1
• Hyponatremia: Especially in elderly; symptoms include headache, weakness, confusion, memory problems 1
• Weight changes: Monitor appetite and weight 1
• Bleeding events: Ecchymosis, epistaxis, petechiae 2

Screen Before Starting

Screen for bipolar disorder - personal or family history of mania/hypomania 1. SSRIs can trigger manic episodes, particularly at higher doses 2. One case series showed escitalopram-induced mania occurred specifically after increasing to 20 mg/day, resolving with dose reduction 4.

Duration of Treatment

Acute episodes of major depression require several months or longer of sustained treatment beyond initial response 1. Systematic evaluation demonstrated benefit of maintenance treatment at 10-20 mg/day in responders 1. However, periodically reassess need for continued treatment 1.

Alternative Antidepressants if SSRI Not Tolerated

If Escitalopram Not Tolerated

Consider switching to another SSRI first before changing classes 2:

• Sertraline: Well-tolerated, less effect on drug metabolism than other SSRIs 5
• Fluoxetine: Very long half-life (reduces discontinuation syndrome risk), but more activating 5

Key SSRI differences 2:

• Paroxetine: More anticholinergic, highest discontinuation syndrome risk, increased suicidal thinking risk - generally avoid 2
• Fluvoxamine: Extensive CYP450 interactions (1A2, 2C19, 2C9, 3A4, 2D6) - avoid if on multiple medications 2
• Sertraline: May require twice-daily dosing at low doses 2

If All SSRIs Not Tolerated

SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors) 2:

• Venlafaxine: Requires 2-4 weeks to titrate to effective dose (150-225 mg/day); monitor blood pressure; taper when discontinuing to avoid withdrawal 6
• Duloxetine: Start 30 mg daily, increase to 60 mg after 1 week 6

Other alternatives:

• Bupropion: Activating, no sexual side effects, contraindicated in seizure disorders 5
• Mirtazapine: Sedating, promotes appetite/weight gain, well-tolerated 5

Discontinuation Protocol

Never stop abruptly - taper gradually to minimize discontinuation syndrome 1. Escitalopram has shorter half-life than fluoxetine, making discontinuation syndrome more likely.

Discontinuation syndrome symptoms 2:

• Dizziness, fatigue, headache, nausea, insomnia
• Electric shock-like sensations, paresthesias
• Anxiety, irritability, mood changes

Tapering strategy:

• Reduce dose gradually over weeks to months (not days) 7
• Consider hyperbolic tapering to very low doses (much lower than therapeutic minimums) to minimize withdrawal 7
• If intolerable symptoms occur, resume previous dose and taper more slowly 1

Common Pitfalls to Avoid

1. Don't automatically increase to 20 mg - many patients respond to 10 mg 1
2. Don't combine with MAOIs or within 14 days - risk of fatal serotonin syndrome 1
3. Don't ignore initial anxiety/agitation - may need dose reduction or slower titration 2
4. Don't use doses >40 mg/day - increased QT prolongation risk without proven additional benefit 2, 3
5. Don't stop abruptly - always taper gradually 1, 7
6. Don't overlook drug interactions - though escitalopram has fewer than other SSRIs, still check for QT-prolonging drugs and serotonergic agents 2